Denied

No. 21-1458

EPA Drug Initiative II v. Hikma Pharmaceuticals USA Inc., et al.

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

Petition DENIED.

DISTRIBUTED for Conference of 6/23/2022.

Waiver of right of respondent Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. to respond filed.

Waiver of right of respondents Hikma Pharmaceuticals USA Inc.; Hikma Pharmaceuticals International Limited; West-Ward Pharmaceuticals International Limited (n/k/a Hikma Pharmaceuticals International Limited) to respond filed.

Petition for a writ of certiorari filed. (Response due June 17, 2022)

Parties

EPA Drug Initiative II, Petitioner, represented by Michael Scott Kasanoff

Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd., Respondent, represented by Constance S. Hunter

Hikma Pharmaceuticals USA Inc.; Hikma Pharmaceuticals International Limited; West-Ward Pharmaceuticals International Limited (n/k/a Hikma Pharmaceuticals International Limited), Respondent, represented by Charles Bennett Klein

 
Last updated: July 3, 2022